Home LiteratureArticle Details
PMID: 3325936 Published · ppublish English Clinical Trial Journal Article

Treatment of chronic postsurgical osteomyelitis with ciprofloxacin.

Pharmaceutisch weekblad. Scientific edition ·Vol. 9 Suppl ·1987-12-11 ·Pages S90-2

Hoogkamp-Korstanje JA

Abstract

Sixteen patients (11F, 5M, age 18-83, mean 59.8 years) with chronic postsurgical osteomyelitis were treated with ciprofloxacin. The dosage was 500 or 750 mg twice daily orally during one to six months; four patients started with 300 mg twice daily intravenously and changed after 3-7 days to oral therapy. Twelve patients had implanted prostheses. The organisms involved were Enterobacteriaceae (11), Pseudomonas aeruginosa (7), Staphylococcus aureus (5), Streptococcus faecalis (4) and Bacteroides fragilis (1). Nine patients had pure cultures, seven mixed cultures. Cure (disappearance of infection symptoms, return of normal function with negative cultures, without resurgery) was obtained in 11 patients, improvement (resurgery required to obtain complete cure) in two. Three patients with infections by Staphylococcus aureus (2) and Pseudomonas aeruginosa (1) failed to respond after one and four months treatment respectively. No side effects were observed.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Bacterial Infections/drug therapy Chronic Disease Ciprofloxacin/therapeutic use Clinical Trials as Topic Female Humans Male Middle Aged Osteomyelitis/drug therapy Surgical Wound Infection/drug therapy
Chemicals
Ciprofloxacin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hoogkamp-Korstanje J A
Laboratory for Public Health, Leeuwarden, The Netherlands.
References (6)
6 references, click to expand
  1. The treatment of bone infections with ceftazidime.
    J Antimicrob Chemother. 1983 Jul;12 Suppl A:229-33 PMID: 6352624
  2. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects.
    N Engl J Med. 1970 Jan 22;282(4):198-206 PMID: 4902833
  3. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Am J Med. 1987 Apr 27;82(4A):266-9 PMID: 3555046
  4. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
    Am J Med. 1987 Apr 27;82(4A):254-8 PMID: 3555044
  5. Clinical experience with cefotaxime in the treatment of serious bone and joint infections.
    Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S465-71 PMID: 6294800
  6. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Am J Med. 1987 Apr 27;82(4A):262-5 PMID: 3555045
Article Info
Journal
Pharmaceutisch weekblad. Scientific edition
Abbr.
Pharm Weekbl Sci
ISSN
0167-6555
Published
1987-12-11
Pages
S90-2
Language
English
Region
Netherlands
NLM ID
7907992
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com